These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 1847527

  • 1. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Swaminathan S, Tomkinson B, Kieff E.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1546-50. PubMed ID: 1847527
    [Abstract] [Full Text] [Related]

  • 2. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES, Tomkinson B, Kieff E.
    J Virol; 1994 Mar 15; 68(3):1449-58. PubMed ID: 8107208
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B, Robertson E, Yalamanchili R, Longnecker R, Kieff E.
    J Virol; 1993 Dec 15; 67(12):7298-306. PubMed ID: 8230453
    [Abstract] [Full Text] [Related]

  • 4. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
    Yajima M, Kanda T, Takada K.
    J Virol; 2005 Apr 15; 79(7):4298-307. PubMed ID: 15767430
    [Abstract] [Full Text] [Related]

  • 5. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S, Yalamanchili R, Kieff E.
    J Virol; 1998 Dec 15; 72(12):9948-54. PubMed ID: 9811732
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI, Wang F, Mannick J, Kieff E.
    Proc Natl Acad Sci U S A; 1989 Dec 15; 86(23):9558-62. PubMed ID: 2556717
    [Abstract] [Full Text] [Related]

  • 7. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E.
    J Virol; 1991 Dec 15; 65(12):6826-37. PubMed ID: 1658376
    [Abstract] [Full Text] [Related]

  • 8. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
    Sano H, Nagata K, Kato K, Kanai K, Yamamoto K, Okuno K, Kuwamoto S, Higaki-Mori H, Sugihara H, Kato M, Murakami I, Kanzaki S, Hayashi K.
    Intervirology; 2013 Dec 15; 56(2):114-21. PubMed ID: 23295915
    [Abstract] [Full Text] [Related]

  • 9. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
    Swaminathan S.
    Virology; 1996 Mar 15; 217(2):532-41. PubMed ID: 8610445
    [Abstract] [Full Text] [Related]

  • 10. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.
    Robertson E, Kieff E.
    J Virol; 1995 Feb 15; 69(2):983-93. PubMed ID: 7815566
    [Abstract] [Full Text] [Related]

  • 11. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
    Tomkinson B, Kieff E.
    J Virol; 1992 Feb 15; 66(2):780-9. PubMed ID: 1309912
    [Abstract] [Full Text] [Related]

  • 12. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A, Zhao B, Kieff E, Aster JC, Wang F.
    J Virol; 2006 Oct 15; 80(20):10139-50. PubMed ID: 17005691
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI, Wang F, Kieff E.
    J Virol; 1991 May 15; 65(5):2545-54. PubMed ID: 1850028
    [Abstract] [Full Text] [Related]

  • 14. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD, Guan M, Park Y, Tawadros R, Yang JY, Gold B, Wu B, Henderson EE.
    AIDS Res Hum Retroviruses; 1997 Jan 20; 13(2):161-71. PubMed ID: 9007201
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F, Marchini A, Kieff E.
    J Virol; 1991 Apr 20; 65(4):1701-9. PubMed ID: 1848303
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E.
    Proc Natl Acad Sci U S A; 1987 May 20; 84(10):3452-6. PubMed ID: 3033649
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
    Guan M, Romano G, Henderson EE.
    Anticancer Res; 1999 May 20; 19(4B):3007-17. PubMed ID: 10652585
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ, Robertson ES.
    J Virol; 2000 Jan 20; 74(2):735-43. PubMed ID: 10623735
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A, Palermo RD, Bayoumy A, Groves IJ, Ba Abdullah M, Holder B, White RE.
    PLoS Pathog; 2018 Feb 20; 14(2):e1006890. PubMed ID: 29462212
    [Abstract] [Full Text] [Related]

  • 20. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X, Yalamanchili R, Harada S, Kieff E.
    J Virol; 1994 Oct 20; 68(10):6188-97. PubMed ID: 8083959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.